Cargando…
Longitudinal change in clinical fracture incidence after initiation of bisphosphonates
SUMMARY: There are differences in the risk profile of patients prescribed alendronate, risedronate, or ibandronate. Observed reductions in fracture incidence over time suggest that the effectiveness of each bisphosphonate in clinical practice has been consistent with their efficacies demonstrated in...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Springer-Verlag
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861765/ https://www.ncbi.nlm.nih.gov/pubmed/19722103 http://dx.doi.org/10.1007/s00198-009-1046-3 |